Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.

  title={Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.},
  author={Yongfeng Zhao and Deborah H. Sultan and Lisa Detering and Hannah P. Luehmann and Yongjian Liu},
  volume={6 22},
Gold nanoparticles have been widely used for oncological applications including diagnosis and therapy. However, the non-specific mononuclear phagocyte system accumulation and potential long-term toxicity have significantly limited clinical translation. One strategy to overcome these shortcomings is to reduce the size of gold nanoparticles to allow renal clearance. Herein, we report the preparation of (64)Cu alloyed gold nanoclusters ((64)CuAuNCs) for in vivo evaluation of pharmacokinetics… 

Figures and Tables from this paper

Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.

This study reveals the potential of CXCR4-targeted 64Cu-CuNCs for TNBC imaging in clinical settings, and provides a useful strategy to design and assess the translational potential of nanoparticles for cancer theranostics.

Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.

    Rubel ChakravartyShreya GoelA. DashW. Cai
    Biology, Chemistry
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
  • 2017
The available options for Radiolabeling of nanoparticles are described and the recent developments in PET imaging of cancer in preclinical and clinical settings using radiolabeled nanoparticles as probes are summarized.

Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.

As an emerging class of nanomaterial, nanoclusters hold great potential for biomedical applications due to their unique sizes and related properties. Herein, we prepared a (64)Cu doped gold

Nanoparticles for PET Imaging of Tumors and Cancer Metastasis

This chapter provides an overview of nanoparticle-based PET agents that have been developed for tumor targeting with a focus on peptides and antibodies.

Radiolabeling of Gold Nanocages for Potential Applications in Tracking, Diagnosis, and Image‐Guided Therapy

An introduction to the chemical synthesis and optical properties of AuNCs is provided, followed by the use of radiolabeled Au NCs in tracking and quantifying their pharmacokinetics, including biodistribution, tumor uptake, and intratumoral distribution.

Clearance Pathways and Tumor Targeting of Imaging Nanoparticles.

Snergetic integration of effective renal clearance and EPR effect offers a promising pathway to design low-toxicity and high-contrast-enhancement imaging nanoparticles that could meet with the clinical translational requirements of regulatory agencies.

Radiolabelling of nanomaterials for medical imaging and therapy.

The most relevant and up-to-date knowledge available in radiolabelling nanomaterials is reviewed to support the efficient clinical translation of future nanomedicinal products for in vivo imaging and/or therapy.

Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECT

The first synthesis of Au nanoparticles doped with 199Au atoms for targeted SPECT tumor imaging in a mouse triple negative breast cancer (TNBC) model is reported, and the stability of the radiolabel can be ensured.

177 Lu-labeled carbon nanospheres: a new entry in the field of targeted radionanomedicine

The potential of 177Lu-labeled carbon nanospheres (177Lu-DOTA-CNS–cRGDfK) for efficient nano-targeting of melanoma tumors expressing integrin αvβ3 is investigated and the future role of radiolabeled carbon Nanospheres in radionanomedicine for efficient targeted therapy of numerous tumor sites is indicated.

Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging.

The ability to directly and quickly image the distribution of Au nanocages in vivo allows us to further optimize their physicochemical properties for a range of theranostic applications.

Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy.

The direct incorporation of (64) Cu into the lattice of the gold nanoparticle structure ensured the radiolabel stability for accurate localization in vivo and demonstrated the great potential of this unique alloyed nanostructure for preclinical and translational imaging.

The biodistribution of gold nanoparticles designed for renal clearance.

The successful immobilization of radioelements in the DTDTPA shell renders possible the follow up of Au@D TDTPA by scintigraphy which showed that Au@ dithiolated polyaminocarboxylate nanoparticles exhibit a safe behaviour after intravenous injection to healthy rats.

In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

The use of multimodal organically modified silica (ORMOSIL) nanoparticles for in vivo bioimaging, biodistribution, clearance, and toxicity studies demonstrate that these multi-modal nanoparticles have potentially ideal attributes for use as biocompatible probes for in vitro imaging.

In vivo biodistribution of nanoparticles.

More systematic in vitro approaches are needed to both guide in vivo work and better correlate nanoparticle properties to their biological effects, and the interaction of these particles with immune cells and their effect on the innate and adaptive immune response needs further characterization.

Multifunctional gold nanoparticles for diagnosis and therapy of disease.

This review covers basic principles and recent findings in gold nanoparticle applications for imaging, therapy and diagnostics, with a focus on reports of multifunctional AuNPs.

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

A thorough discussion of the physiologic aspects of nanoparticle clearance, focusing on renal mechanisms, is presented and an overview of current research investigating clearance of specific types of nanoparticles and nano-sized macromolecules is provided.

Design considerations for tumour-targeted nanoparticles.

This study shows that quantum dots functionalized with high-affinity small-molecule ligands that target tumours can also be cleared by the kidneys if their hydrodynamic diameter is less than this value, which sets an upper limit of 5-10 ligands per quantum dot for renal clearance.

Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent.

It is demonstrated that Gado-6Si-NP display optimal biodistribution properties, enabling them to be developed as multimodal agents for in vivo imaging and theragnostics, especially in oncological applications.